Han-Suk Ryu

18PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 24, 2026
Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance.

|Jul 22, 2025
MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.

Cheng Hyun Lee, Soo Young Park, Jae Seok Lee

|Nov 08, 2023
Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.

Ilias P Nikas, Soo-Young Park, Min Ji Song

|Nov 04, 2023
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.

Ji Eun Choi, Jae Seok Lee, Min-Sun Jin

|Mar 14, 2023
Clinical application of the anti-human telomerase reverse transcriptase (hTERT) antibody (SCD-A7) immunocytochemistry in liquid-based urine cytology: A prospective, single institute study.

Ji Hye Moon, Ilias P Nikas, Kyung Chul Moon

|Sep 02, 2022
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.

Bohyun Kim, Minsun Jung, Kyung Chul Moon

Pageof 3

Frequent Collaborators

4 joint publications

Hyebin Lee

3 joint publications

Seock-Ah Im

3 joint publications

Ilias P Nikas

2 joint publications

Minsun Jung